Biological Lattice Industries Corp. (BLI)

About Biological Lattice Industries Corp. (BLI)

Biological Lattice Industries (BLI) aims to democratize biofabrication through intelligent automation. Their mission is to simplify biofabrication processes, empowering researchers and companies to focus on breakthroughs by making advanced 3D bioprinting intuitive and accessible.

Products & Services

Loominus Studio:A user-friendly software platform for creating and managing 3D biofabrication workflows using graphs. Features include no-code configuration, procedural parametric CAD modeling, advanced toolpath control, and real-time monitoring.

BioLoom:A state-of-the-art multi-tool 3D bioprinter integrating various extrusion-based printing technologies such as Direct Ink Writing, Melt Electrowriting, Electrospinning, Fused Filament Fabrication, and Melt Extrusion. It includes active sterility and environmental control for reproducible outcomes.

Specialties

3D Biofabrication Intelligent Automation 3D Bioprinting Workflows Multi-Material 3D Printing GMP-Compliant Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Pre-Seed T: - FT: Pre-Seed	A: 1800000 MR: - FA: $1.8 million FAN: 1800000	D: 2024-10-18 FD: 2024-10-18	1 investors

Pre-Seed Latest

2024-10-18

$1.8M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News